What do recent clinical guidelines say about the benefits versus risks of initiating hormone replacement therapy for women who are well past the typical age of menopause?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What do recent clinical guidelines say about the benefits versus risks of initiating hormone replacement therapy for women who are well past the typical age of menopause?
2 real searches · 1 real-search pass
clinical guidelines initiating menopausal hormone therapy women older than 60 or more than 10 years since menopause benefits risks 2025 2026 NAMS ACOG Endocrine SocietyGoogle ↗
OBSERVEDConsequence
NAMS 2022 hormone therapy position statement timing hypothesis older than 60 10 years menopause risks initiationGoogle ↗
OBSERVEDConsequence
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
ChatGPT real searches (2)
Classes come from the query-classifier (a local Laya model). 2 of 2 calls are low-confidence (under 50%) — hover a query in the table to see its confidence.
Searches and sources
ChatGPT2 real searches · gpt-6
clinical guidelines initiating menopausal hormone therapy women older than 60 or more than 10 years since menopause benefits risks 2025 2026 NAMS ACOG Endocrine Society Google ↗
NAMS 2022 hormone therapy position statement timing hypothesis older than 60 10 years menopause risks initiation Google ↗
- The 2022 hormone therapy position statement of The North American Menopause Society · pubmed.ncbi.nlm.nih.gov
- NAMS Hormone Therapy Position Statement 2022 Guideline Summary · guidelinecentral.com
- ACOG Clinical Practice Guideline: Management of... : Obstetrics & Gynecology · doi.org
- Hormone therapy safety · womenshealth.gov
- NAMS 2022 Hormone Therapy Position Statement · menopause.org.au
- The 2022 hormone therapy position statement of... : Menopause · doi.org
- FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies · fda.gov
- Initiation of Hormone Therapy After Age 65 Remains Risky but Still Works for Some Women · menopause.org
- FDA Approves Labeling Changes to Menopausal Hormone Therapy Products · fda.gov
- Menopausal Hormone Therapies with Updated Prescribing Information · fda.gov
Queries
2 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
clinical guidelines initiating menopausal hormone therapy women older than 60 or more than 10 years since menopause benefits risks 2025 2026 NAMS ACOG Endocrine Society OBSERVED | Google ↗ AI Mode ↗ | — | Consequence | — | — | 1x of 1 | |
NAMS 2022 hormone therapy position statement timing hypothesis older than 60 10 years menopause risks initiation OBSERVED | Google ↗ AI Mode ↗ | — | Consequence | — | — | 1x of 1 |